Jushi Sees Sales Slip In First Quarter

May 12, 2023 · Green Market Report

Missouri legalization impacted Illinois sales.

Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF) announced its financial results for the first quarter ending March 31, 2023. Total revenue increased 12.9% to $69.9 million over last year’s $61.9 million, but fell sequentially by 9% from $76.8 million. It also missed the Yahoo! Finance average analyst estimate for revenue of $74 million.

Jushi said that the increase in revenue was due to new dispensary openings from build outs and acquisitions. The company acquired Apothecarium and NuLeaf in Nevada during March 2022 and April 2022, respectively, and opened new Beyond Hello dispensaries in Ohio, Pennsylvania, and Virginia in 2022. The increase in retail revenue however, was partially offset by declines in revenue in:

  • Illinois, due to the impact of the state of Missouri moving to recreational use
  • Pennsylvania due to increased retail competition and lower retail market prices.

The net loss of $12.4 million, was an improvement of $7.3 million over last year’s net loss of $19.8 million in the same time period. The loss per share was ($0.06), which was better than the analyst estimate for ($0.12).

“In the first quarter, our efficiency and cost savings plan resulted in very encouraging improvements to our margins and profitability,” said Jim Cacioppo, Chief Executive Officer, Chairman, and Founder of the Company. “Our aggressive steps to responsibly right size the business, improve efficiencies and manage costs created an approximate 13.0% year-over-year reduction in operating expenses. In April, we further executed against our cost-savings initiatives with the implementation of our new retail labor model which is expected to meaningfully cut our labor hour costs. Additionally, we continue to make upgrades throughout our grower-processor footprint to drive operational efficiencies for further savings throughout the remainder of the year.”

Expenses Trimmed

Operating expenses were trimmed to $32.5 million versus $37.3 million last year, a decrease of $4.9 million, or 13.0% year-over-year. Salaries, wages, and employee-related expenses decreased due to a reduction in the number of employees as the company works to right-size the organization. At the end of March, Jushi had approximately $19.4 million of cash, cash equivalents and restricted cash.

In 2023, the company said it expects capital expenditures for new projects to be approximately $13.0 million, of which approximately $6.0 million is discretionary growth capital, as a substantial amount of its expansion projects in Pennsylvania and Virginia were completed in fiscal year 2022. The company said it had approximately $209.0 million in principal amount of total debt, excluding leases and property, plant, and equipment financing obligations.

Expansion Plans

Mr. Cacioppo continued, “With five state-level vertically integrated operations that are all still ramping up to our desired operating performance, we are increasing our ability to sell-through Jushi-branded products at our own retail network and continuing to grow our wholesale operations. Our wholesale business revenue has nearly doubled year-over-year, while retail sales increased over 7.5% year-over-year. We look forward to the launch of our new high-end flower line, Hijinks, and other innovative product forms across our house of brands to better serve customers and grow profitability of the Company. I would note that our grower-processor operations had significant improvement in gross profit margin fueled by efficiency gains. We realized benefits from cost savings initiatives, ramp-up of new production, and other enhancements made at our Massachusetts, Pennsylvania, and Virginia facilities along with improved retail operating performance.”

Mr. Cacioppo concluded, “In the second quarter, we were pleased to strengthen our capital position with a $20.0 million debt financing to strengthen our balance sheet. Through our cost controls, ramp-up of our grower processors, and our operational discipline our goal is to generate positive operating cash flow for debt pay-downs by the fourth quarter of 2023.” (Full Story)

In category:Business
Next Post

California cannabis companies hire credit group to monitor retailers over unpaid invoices

A group of California distributors and brands representing more than half the state’s wholesale B2B cannabis market has hired a credit association to rate retailers in the hopes of reducing the hundreds of thousands of dollars in unpaid invoices –…
Read
Previous Post

Charlotte's Web Maintains Strong Gross Profit Margins Amid Net Revenue Decline

There was a 57.7% improvement in the adjusted EBITDA loss over the year. Hemp-based CBD giant Charlotte’s Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) reported its first-quarter financial results on Thursday ending March 31, 2023. Despite a 12.1% year-over-year fall in net…
Read
Random Post

NFL Is Putting More Money Into Research On CBD As An Opioid Alternative For Players With Concussions

The National Football League (NFL) and its players union announced on Thursday that they are jointly awarding another round of funding to support independent research on the therapeutic benefits of CBD as a pain treatment alternative to opioids for players…
Read
Random Post

Kentucky Passes Medical Cannabis Legalization Bill

Kentucky lawmakers on Thursday passed a bill to legalize medical cannabis in the state, moving the legislation to Democratic Gov. Andy Beshear (D), Spectrum News 1 reports. Beshear, on Twitter, said he plans to “proudly” sign the legislation today. The measure does not include…
Read
Random Post

Germany’s Cabinet Passes Adult-Use Cannabis Reforms

Germany’s cabinet on Wednesday passed a bill to legalize adult cannabis use and cultivation, Reuters reports. The measure still requires approval from parliament.  Under the proposal, adults would be allowed to possess up to 25 grams, grow up to three plants, and…
Read
Random Post

New Study Finds Prohibition Promotes Unregulated Cannabis Use

Prohibition may unintentionally promote the use of delta 8 THC in states without medical or adult-use cannabis laws, according to a new federally funded study published in the Journal of the American Medical Association. Cannabinoids synthesized from hemp have not-so-quietly…
Read